1. Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute-Donostia University Hospital; University of the Basque Country (UPV/EHU); San Sebastian Spain
2. National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd); Carlos III National Institute of Health; Madrid Spain
3. Experimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL); University of Salamanca; Salamanca Spain
4. Sorbonne Universités, UPMC Université Paris 06, INSERM, Saint-Antoine Research Center, Paris, and Fondation ARC; Villejuif France
5. IKERBASQUE, Basque Foundation for Science; Bilbao Spain
6. Division of Hepatology; CIMA of the University of Navarra; Pamplona Spain
7. Proteored-ISCIII, Proteomics Unit, Navarrabiomed, Navarra Health Department; Public University of Navarra, Navarra Institute for Health Research (IdiSNA); Pamplona Spain
8. CIC bioGUNE, Bizkaia Technology Park; Derio Bizkaia Spain
9. CIBERONC
10. Biochemistry and Molecular Biology Department; University of the Basque Country (UPV/EHU); Bilbao Spain
11. Liver Center; Yale University School of Medicine; New Haven CT
12. Department of Gastroenterology; Università Politecnica delle Marche; Ancona Italy
13. Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Academic Medical Centre; University of Amsterdam; Amsterdam The Netherlands
14. Division of Gastroenterology and Hepatology; Mayo Clinic; Rochester MN